BATF2
Basic information
Region (hg38): 11:64987945-64997018
Links
Phenotypes
GenCC
Source: 
ClinVar
This is a list of variants' phenotypes submitted to 
- not_specified (42 variants)
 
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the BATF2 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000138456.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum | 
|---|---|---|---|---|---|---|
| synonymous | 0 | |||||
| missense | 40 | 42 | ||||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 0 | 0 | 40 | 2 | 0 | 
GnomAD
Source: 
| Gene | Type | Bio Type | Transcript | Coding Exons | Length | 
|---|---|---|---|---|---|
| BATF2 | protein_coding | protein_coding | ENST00000301887 | 3 | 9103 | 
| pLI Probability LOF Intolerant  | pRec Probability LOF Recessive  | Individuals with no LOFs  | Individuals with Homozygous LOFs  | Individuals with Heterozygous LOFs  | Defined | p | 
|---|---|---|---|---|---|---|
| 0.585 | 0.377 | 0 | 0 | 0 | 0 | 0.00 | 
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 0.373 | 139 | 152 | 0.915 | 0.00000859 | 1720 | 
| Missense in Polyphen | 20 | 30.736 | 0.65071 | 402 | ||
| Synonymous | 0.177 | 69 | 70.9 | 0.973 | 0.00000409 | 617 | 
| Loss of Function | 1.53 | 0 | 2.73 | 0.00 | 1.16e-7 | 32 | 
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p | 
|---|---|---|
| African & African-American | 0.00 | 0.00 | 
| Ashkenazi Jewish | 0.00 | 0.00 | 
| East Asian | 0.00 | 0.00 | 
| Finnish | 0.00 | 0.00 | 
| European (Non-Finnish) | 0.00 | 0.00 | 
| Middle Eastern | 0.00 | 0.00 | 
| South Asian | 0.00 | 0.00 | 
| Other | 0.00 | 0.00 | 
dbNSFP
Source: 
- Function
 - FUNCTION: AP-1 family transcription factor that controls the differentiation of lineage-specific cells in the immune system. Following infection, participates in the differentiation of CD8(+) thymic conventional dendritic cells in the immune system. Acts via the formation of a heterodimer with JUN family proteins that recognizes and binds DNA sequence 5'-TGA[CG]TCA-3' and regulates expression of target genes (By similarity). Selectively suppresses CYR61/CCN1 transcription and hence blocks the downstream cell proliferation signals produced by CYR61 and inhibits CYR61-induced anchorage-independent growth and invasion in several cancer types, such as breast cancer, malignant glioma and metastatic melanoma. Possibly acts by interfering with AP-1 binding to CYR61 promoter. {ECO:0000250, ECO:0000269|PubMed:20531301}.;
 
Recessive Scores
- pRec
 - 0.0761
 
Intolerance Scores
- loftool
 - 0.520
 - rvis_EVS
 - 0.17
 - rvis_percentile_EVS
 - 65.76
 
Haploinsufficiency Scores
- pHI
 - 0.0766
 - hipred
 - N
 - hipred_score
 - 0.412
 - ghis
 
Essentials
- essential_gene_CRISPR
 - N
 - essential_gene_CRISPR2
 - N
 - essential_gene_gene_trap
 - N
 - gene_indispensability_pred
 - N
 - gene_indispensability_score
 - 0.451
 
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium | 
| Primary Immunodeficiency | Medium | Medium | Medium | 
| Cancer | Medium | Medium | Medium | 
Mouse Genome Informatics
- Gene name
 - Batf2
 - Phenotype
 - mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); immune system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);
 
Gene ontology
- Biological process
 - regulation of transcription by RNA polymerase II;defense response to protozoan;myeloid dendritic cell differentiation
 - Cellular component
 - nucleus
 - Molecular function
 - RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;protein binding